{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:29:20Z","timestamp":1761766160434},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.eururo.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T20:30:24Z","timestamp":1492201824000},"page":"345-351","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation Therapy"],"prefix":"10.1016","volume":"72","author":[{"given":"Prasanna","family":"Sooriakumaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommy","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"Akre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Widmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freddie","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Steineck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Peter","family":"Wiklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2017.04.002_bib0140","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rates","volume":"61","author":"Center","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0145","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.eururo.2006.10.045","article-title":"The natural history of noncastrate metastatic prostate cancer after radical prostatectomy","volume":"51","author":"Yossepowitch","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent\u2014update 2013","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0155","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0160","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0140-6736(01)06103-7","article-title":"Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial","volume":"358","author":"Mickisch","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2017.04.002_bib0165","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa003013","article-title":"Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer","volume":"345","author":"Flanigan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2017.04.002_bib0170","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2013.11.012","article-title":"Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor?. A SEER-based study","volume":"65","author":"Culp","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0175","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/00365590903024577","article-title":"PCBaSe Sweden: a register-based resource for prostate cancer research","volume":"43","author":"Hagel","year":"2009","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0180","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/ije\/dys068","article-title":"Cohort profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0","volume":"42","author":"Van Hemelrijck","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0185","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.juro.2010.10.061","article-title":"Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden","volume":"185","author":"Berglund","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0190","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1502","article-title":"Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes","volume":"348","author":"Sooriakumaran","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2017.04.002_bib0195","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.eururo.2017.04.002_bib0200","first-page":"CD007565","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","volume":"8","author":"Elattar","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2017.04.002_bib0205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","article-title":"Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia","volume":"5","author":"Glehen","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0210","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1200\/JCO.2004.10.218","article-title":"Use of surgery among elderly patients with stage IV colorectal cancer","volume":"22","author":"Temple","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0215","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1200\/JCO.2008.17.0563","article-title":"Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer","volume":"27","author":"Weckermann","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0220","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1203543","article-title":"A perspective on cancer cell metastasis","volume":"331","author":"Chaffer","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.eururo.2017.04.002_bib0225","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-08-1754","article-title":"Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence","volume":"15","author":"Morgan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2017.04.002_bib0230","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0022-5347(05)64562-4","article-title":"Impact of previous local treatment for prostate cancer on subsequent metastatic disease","volume":"168","author":"Thompson","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eururo.2013.03.053","article-title":"Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy","volume":"65","author":"Touijer","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2013.05.033","article-title":"The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature","volume":"66","author":"Gakis","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0245","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.eururo.2014.04.009","article-title":"Role of radical prostatectomy in metastatic prostate cancer: data from the Munich Cancer Registry","volume":"66","author":"Gratzke","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0250","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/00365590802078583","article-title":"Reliability of death certificates in prostate cancer patients","volume":"42","author":"Fall","year":"2008","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0255","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eururo.2012.08.001","article-title":"Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study","volume":"63","author":"Rider","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0260","doi-asserted-by":"crossref","first-page":"E250","DOI":"10.1111\/bju.12169","article-title":"Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer","volume":"112","author":"Won","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2017.04.002_bib0265","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.juro.2006.06.069","article-title":"Metastatic prostate cancer-does treatment of the primary tumor matter?","volume":"176","author":"Swanson","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.04.002_bib0270","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.eururo.2015.05.023","article-title":"A multi-institutional analysis of perioperative outcomes in 106 men who underwent radical prostatectomy for distant metastatic prostate cancer at presentation","volume":"69","author":"Sooriakumaran","year":"2016","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283817302828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283817302828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T13:53:29Z","timestamp":1535896409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283817302828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0302283817302828"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2017.04.002","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation Therapy","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}